FULTON BANK, N.A. - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.

Quarter-by-quarter ownership
FULTON BANK, N.A. ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2022$210,000
-34.0%
4,567
-4.9%
0.01%
-28.6%
Q4 2021$318,000
+7.8%
4,801
+1.7%
0.01%0.0%
Q3 2021$295,000
-12.5%
4,723
+15.9%
0.01%
-12.5%
Q2 2021$337,000
+32.7%
4,076
+6.5%
0.02%
+23.1%
Q1 2021$254,000
-9.6%
3,827
+4.4%
0.01%
-13.3%
Q4 2020$281,0003,6660.02%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q1 2022
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,346$62,945,00041.38%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$250,206,00032.27%
Aquilo Capital Management, LLC 365,926$28,078,0005.84%
L1 Capital Pty Ltd 298,687$23,127,0004.32%
First Light Asset Management, LLC 704,449$54,052,0004.00%
ACUTA CAPITAL PARTNERS, LLC 139,000$10,665,0002.90%
Evolutionary Tree Capital Management, LLC 48,265$3,703,0002.82%
Parkman Healthcare Partners LLC 127,171$9,758,0002.50%
Capital Impact Advisors, LLC 88,183$6,766,0001.66%
Tri Locum Partners LP 56,003$4,297,0001.56%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders